Javier San Martin

Track

Insider profile

Currently holds a position at Arrowhead Pharmaceuticals Inc

Performance

Overall performance
3.0
Performance over holding periods
3.0
30 days 90 days 120 days
Average return 4% 8.2% 15.1%
Success rate 99% 68% 82%
Transactions
5 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chief Medical Officer Arrowhead Pharmaceuticals Inc Nov. 18, 2019 -
Vice President - Clinical Development Ultragenyx Pharmaceutical Inc Dec. 1, 2013 - Jan. 1, 2014
Javier San Martin's trades of LeonaBio Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US LeonaBio Inc (ATHA)
Transaction date
Sale
Price
207.23
Quantity 25,053 -28.7%
Value US$1,363,530
US LeonaBio Inc (ATHA)
Transaction date
Sale
Price
17.70
Quantity 35,544 -46.5%
Value US$1,334,223
US LeonaBio Inc (ATHA)
Transaction date
Sale
Price
232.57
Quantity 31,599 +6.1%
Value US$242,190
US LeonaBio Inc (ATHA)
Transaction date
Proposed sale
Price
0.29
Quantity 10,842
Value US$3,182
US LeonaBio Inc (ATHA)
Transaction date
Sale
Price
0.56
Quantity 10,826 -23.2%
Value US$6,083
US LeonaBio Inc (ATHA)
Transaction date
Proposed sale
Price
0.56
Quantity 10,826
Value US$6,083
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-05 2026-03-04
US LeonaBio Inc (ATHA)
S Sale
25,053 -28.7%
207.23
US$1,363,530 		25,053 -28.7% 207.23 US$1,363,530
2026-01-05 2026-01-02
US LeonaBio Inc (ATHA)
S Sale
35,544 -46.5%
17.70
US$1,334,223 		35,544 -46.5% 17.70 US$1,334,223
2025-07-02 2025-07-01
US LeonaBio Inc (ATHA)
S Sale
31,599 +6.1%
232.57
US$242,190 		31,599 +6.1% 232.57 US$242,190
2025-07-01 2025-07-01
US LeonaBio Inc (ATHA)
PrS Proposed sale
10,842
0.29
US$3,182 		10,842 0.29 US$3,182
2025-01-03 2025-01-02
US LeonaBio Inc (ATHA)
S Sale
10,826 -23.2%
0.56
US$6,083 		10,826 -23.2% 0.56 US$6,083
2025-01-02 2025-01-02
US LeonaBio Inc (ATHA)
PrS Proposed sale
10,826
0.56
US$6,083 		10,826 0.56 US$6,083
2024-01-08 2024-01-05
PlS Planned sale
4,403 -2.2%
35.64
US$156,923 		4,403 -2.2% 35.64 US$156,923
2024-01-08 2024-01-05
PlS Planned sale
3,100 -1.5%
35.03
US$108,593 		3,100 -1.5% 35.03 US$108,593
2024-01-08 2024-01-05
PlS Planned sale
800 -0.4%
34.11
US$27,288 		800 -0.4% 34.11 US$27,288
2024-01-05 2024-01-05
PrS Proposed sale
8,303
35.26
US$292,774 		8,303 35.26 US$292,774
2023-11-22 2023-11-20
S Sale
4,942 -3.6%
29.00
US$143,318 		4,942 -3.6% 29.00 US$143,318
2023-11-22 2023-11-20
S Sale
14,758 -9.7%
28.73
US$423,997 		14,758 -9.7% 28.73 US$423,997
2023-11-20 2023-11-20
PrS Proposed sale
19,700
28.80
US$567,273 		19,700 28.80 US$567,273
2022-11-22 2022-11-21
PlS Planned sale
200 -0.2%
30.62
US$6,124 		200 -0.2% 30.62 US$6,124
2022-11-22 2022-11-21
PlS Planned sale
19,300 -17.4%
29.98
US$578,614 		19,300 -17.4% 29.98 US$578,614
2021-11-22 2021-11-19
PlS Planned sale
100 -0.1%
70.99
US$7,099 		100 -0.1% 70.99 US$7,099
2021-11-22 2021-11-19
PlS Planned sale
5,696 -4.9%
70.01
US$398,777 		5,696 -4.9% 70.01 US$398,777
2021-11-22 2021-11-19
PlS Planned sale
13,704 -10.5%
69.01
US$945,713 		13,704 -10.5% 69.01 US$945,713
2020-11-20 2020-11-19
PlS Planned sale
19,500 -13.0%
69.39
US$1,353,105 		19,500 -13.0% 69.39 US$1,353,105